M.D. Anderson Cancer Center: Mouth Neoplasms trials

The registry lists 21 Mouth Neoplasms studies with M.D. Anderson Cancer Center as lead sponsor. 4 are open to participants now and 2 have results posted.

Early Phase 1 1Phase 1 4Phase 2 3Phase 3 1Phase 4 1No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Clinical and Molecular Features of Oral Premalignancy and Oral CancerRecruitingNCT06550050
• Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity and HPV-negative Oropharyngeal Squamous Cell CarcinomaRecruitingNCT06448026Phase 2
• Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base TumorsRecruitingNCT04265430Phase 4
• Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing SurgeryRecruitingNCT01269190Not applicable
• Pembrolizumab in Treating Patients With High Risk Oral Intraepithelial NeoplasiaCompletedNCT02882282Phase 2Results posted
• Erlotinib Prevention of Oral Cancer (EPOC)CompletedNCT00402779Phase 3Results posted
• Customized 3D Printed Oral Stents During Head and Neck RadiotherapyActive, not recruitingNCT04870762Phase 2
• Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid TumorsTerminatedNCT03420963Phase 1
• Multimodal Imaging for Surveillance in Patients With Oral Potentially Malignant DisordersActive, not recruitingNCT02790853Early Phase 1
• Intensity-Modulated Proton Therapy (IMPT) or TransOral Robotic Surgery (TORS) for the Treatment of Low-Risk Oropharynx Squamous CellStatus unknownNCT02663583
• Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer PatientsActive, not recruitingNCT02253238Not applicable
• Diagnostic Aids for Detection and Diagnosis of Oral CancerWithdrawnNCT02251639Phase 1
• Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign DiseaseTerminatedNCT01552434Phase 1
• Complete Decongestive Therapy (CDT) for Treatment of Head and Neck LymphedemaWithdrawnNCT00951470Not applicable
• Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral CancerActive, not recruitingNCT00542373Not applicable
• Spectroscopy for Diagnostic Assessment of Oral Mucosal LesionsCompletedNCT00507182Not applicable
• Evaluation of a Multispectral Vision Enhancement System for Assessment of Oral Mucosal LesionsCompletedNCT00502580
• In Vivo Confocal Imaging of Oral MucosaCompletedNCT00502125
• Oral Margin Spectroscopy Detection Using Optical SpectroscopyCompletedNCT00439205
• Smoking Status and Body Image in Oral Cancer PatientsCompletedNCT00412490
• Wild Type p53 Adenovirus for Oral PremalignanciesTerminatedNCT00410865Phase 1